Mary Relling, PharmD, Announced as 2020 William B. Abrams Lecturer
Join ASCPT and the US Food and Drug Administration (FDA) for the 2020 William B. Abrams lecture, to be held on Thursday, May 14, 2020, 1:30 PM – 3:00 PM for Dr. Relling’s presentation on “Clinical Implementation of Pharmacogenetics.”
Mary Relling, PharmD, Professor, St Jude Children's Research Hospital. Dr. Relling has been a member of ASCPT since 1989. Her lecture will provide an overview of the Clinical Pharmacogenetics Implementation Consortium (CPIC®), developed in 2009, to write, curate, and update freely available, peer-reviewed, and detailed gene/drug pharmacogenetic clinical practice guidelines with accompanying computational tables to facilitate the appropriate use of pharmacogenetic tests in clinical care. In addition, the implementation of the CPIC guidelines in a clinical protocol at St. Jude’s, PG4KDS, with an aim to preemptively test all eligible children at the institute and implement all CPIC guidelines by placing test results, with the necessary clinical decision support tools to guide prescribing, in an electronic health record will be discussed.
Registration for the Abrams Lecture is complimentary; however, advance registration is required.
Click here for details and to register and stay tuned for information on attending this special event virtually.